ArticleJCI insight2023

LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.

Anbarasu Kumaraswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.